The clinical laboratory: a decision maker hub

Objectives: We aimed to share a new laboratory model based on laboratory knowledge, meaningful use of information technology, and partnership with clinicians, to lead the appropriate use of laboratory testing and clinical decision making in the diagnosis of as-yet-undiagnosed disease. More specifica...

Descripción completa

Detalles Bibliográficos
Autores: Salinas, M, Lopez-Garrigos, M, Flores, E, Martin, E, Leiva-Salinas, C
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2021
País:España
Institución:Instituto de Investigación Biomédica y Sanitaria de Alicante (ISABIAL)
Repositorio:r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
OAI Identifier:oai:isabial.fundanetsuite.com:p8350
Acceso en línea:https://isabial.portalinvestigacion.com/publicaciones8350
https://www.degruyter.com/document/doi/10.1515/cclm-2021-0421/html
Access Level:acceso abierto
Palabra clave:appropriateness
clinical laboratory
demand management
under-request
id ES_8a70fddf2d57706e1efe8c83862e44bf
oai_identifier_str oai:isabial.fundanetsuite.com:p8350
network_acronym_str ES
network_name_str España
repository_id_str
spelling The clinical laboratory: a decision maker hubSalinas, MLopez-Garrigos, MFlores, EMartin, ELeiva-Salinas, Cappropriatenessclinical laboratorydemand managementunder-requestObjectives: We aimed to share a new laboratory model based on laboratory knowledge, meaningful use of information technology, and partnership with clinicians, to lead the appropriate use of laboratory testing and clinical decision making in the diagnosis of as-yet-undiagnosed disease. More specifically, we evaluate the role of eight different opportunistic interventions to diagnose certain asymptomatic disorders, by means of the automatic registration of appropriate laboratory testing according to different scenarios. Methods: This is a retrospective longitudinal study to evaluate the impact of laboratory interventions on the diagnosis of different diseases and on patient care, including data from January 2012 to September 2020. Results: Overall, the above strategies have so far identified 2063 patients with clinically relevant as-yet-undiagnosed disorders who would have otherwise remained occult, such as for instance, primary hyperparathyroidism, diabetes, and hypomagnesemia. Conclusions: We are facing a new laboratory model, a leading laboratory rather than a passive traditional laboratory, not just to intervene in clinical decision-making, but to make the clinical decision, through the identification of patients with occult disease.WALTER DE GRUYTER GMBH2021info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://isabial.portalinvestigacion.com/publicaciones8350https://www.degruyter.com/document/doi/10.1515/cclm-2021-0421/htmlCLINICAL CHEMISTRY AND LABORATORY MEDICINEISSN: 14346621ISSNe: 14374331reponame:r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicanteinstname:Instituto de Investigación Biomédica y Sanitaria de Alicante (ISABIAL)Inglésinfo:eu-repo/semantics/openAccessoai:isabial.fundanetsuite.com:p83502026-06-12T10:20:37Z
dc.title.none.fl_str_mv The clinical laboratory: a decision maker hub
title The clinical laboratory: a decision maker hub
spellingShingle The clinical laboratory: a decision maker hub
Salinas, M
appropriateness
clinical laboratory
demand management
under-request
title_short The clinical laboratory: a decision maker hub
title_full The clinical laboratory: a decision maker hub
title_fullStr The clinical laboratory: a decision maker hub
title_full_unstemmed The clinical laboratory: a decision maker hub
title_sort The clinical laboratory: a decision maker hub
dc.creator.none.fl_str_mv Salinas, M
Lopez-Garrigos, M
Flores, E
Martin, E
Leiva-Salinas, C
author Salinas, M
author_facet Salinas, M
Lopez-Garrigos, M
Flores, E
Martin, E
Leiva-Salinas, C
author_role author
author2 Lopez-Garrigos, M
Flores, E
Martin, E
Leiva-Salinas, C
author2_role author
author
author
author
dc.subject.none.fl_str_mv appropriateness
clinical laboratory
demand management
under-request
topic appropriateness
clinical laboratory
demand management
under-request
description Objectives: We aimed to share a new laboratory model based on laboratory knowledge, meaningful use of information technology, and partnership with clinicians, to lead the appropriate use of laboratory testing and clinical decision making in the diagnosis of as-yet-undiagnosed disease. More specifically, we evaluate the role of eight different opportunistic interventions to diagnose certain asymptomatic disorders, by means of the automatic registration of appropriate laboratory testing according to different scenarios. Methods: This is a retrospective longitudinal study to evaluate the impact of laboratory interventions on the diagnosis of different diseases and on patient care, including data from January 2012 to September 2020. Results: Overall, the above strategies have so far identified 2063 patients with clinically relevant as-yet-undiagnosed disorders who would have otherwise remained occult, such as for instance, primary hyperparathyroidism, diabetes, and hypomagnesemia. Conclusions: We are facing a new laboratory model, a leading laboratory rather than a passive traditional laboratory, not just to intervene in clinical decision-making, but to make the clinical decision, through the identification of patients with occult disease.
publishDate 2021
dc.date.none.fl_str_mv 2021
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://isabial.portalinvestigacion.com/publicaciones8350
https://www.degruyter.com/document/doi/10.1515/cclm-2021-0421/html
url https://isabial.portalinvestigacion.com/publicaciones8350
https://www.degruyter.com/document/doi/10.1515/cclm-2021-0421/html
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv WALTER DE GRUYTER GMBH
publisher.none.fl_str_mv WALTER DE GRUYTER GMBH
dc.source.none.fl_str_mv CLINICAL CHEMISTRY AND LABORATORY MEDICINE
ISSN: 14346621
ISSNe: 14374331
reponame:r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname:Instituto de Investigación Biomédica y Sanitaria de Alicante (ISABIAL)
instname_str Instituto de Investigación Biomédica y Sanitaria de Alicante (ISABIAL)
reponame_str r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
collection r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869412716525912064
score 15.812455

Similares en LA Referencia